SECONDARY NUMB Lidocaine Phenylephrine Gel

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
SECONDARY NUMB Lidocaine Phenylephrine Gel
Generic name
LIDOCAINE, PHENYLEPHRINE HYDROCHLORIDE
Manufacturer
LALANI Rx Consulting, Inc.
Product type
HUMAN OTC DRUG
SPL set ID
0f13f7b5-e3b1-451e-a6d6-e7e15bd04443
SPL ID
0976eff9-48c6-1669-e063-6394a90a8240
Version
2
Effective date
2023-11-06
Source export date
2026-10-12
Source partition
8
Source file
https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-12/fa098e7c5cff0b1ab653ce934059d1f4b90b860bafc0383a1f66223ce1037518/drug-label-0008-of-0014.json.zip
Source manifest SHA-256
7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run
20261013T011858Z
Imported at
2026-10-13 02:09:27
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Do not use if you have ▪ heart disease ▪ high blood pressure ▪ thyroid disease ▪ diabetes ▪ difficuly in urination Ask a doctor before use if you are • presently taking medicine for high blood pressure or depression When using this product • do not put it into the rectum by using fingers or any mechanical device or applicator Stop use and ask a doctor if • bleeding occurs • condition worsens or does not improve within 7 days • redness, irritation, swelling, pain or other symptoms occur. If allergic reaction to product occurs. Keep out of reach of children. If swallowed, call poison control centre or get medical help right away

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.